Revvity Inc. RVTY
151.11
0.43
0.29%
as of 25 Sep
- Market cap
- $16.8B
- P/E
- 72.0×
Follow RVTY
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Revvity Inc. (RVTY) P/B ratio
As of 25 September 2026, Revvity Inc. (RVTY) trades at a P/B ratio of 2.3×. Over the past ten years it has ranged from 1.3× (April 2026) to 5.1× (December 2020); the current reading is higher than 32% of that period. That is below the Diagnostics & Research industry median of 3.1× and below the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.6× | (12.97%) |
| FY2024 | 1.8× | 2.16% |
| FY2023 | 1.7× | (27.47%) |
| FY2022 | 2.4× | (26.26%) |
| FY2021 | 3.3× | (23.65%) |
| FY2020 | 4.3× | 12.01% |
| FY2019 | 3.8× | 13.83% |
| FY2018 | 3.4× | 3.58% |
| FY2017 | 3.2× | 20.41% |
| FY2016 | 2.7× | (5.67%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 1.7× | 25.88% |
| Mar 2026 | 1.4× | (12.27%) |
| Dec 2025 | 1.6× | 13.39% |
| Sep 2025 | 1.4× | (8.82%) |
| 42 more quarters | Free account |
Against its own ten years
Low 1.3×
High 5.1×
Ten-year median
2.8×
Current reading's percentile
32
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| ICLR ICON PLC compare | 1.4× |
| RVTY Revvity Inc. | 2.3× |
| LH Labcorp Holdings Inc. compare | 2.9× |
| DGX Quest Diagnostics Incorporated compare | 3.4× |
| CRL Charles River Laboratories International, Inc. compare | 4.9× |
| TWST Twist Bioscience Corporation compare | 25.7× |
| MEDP Medpace Holdings, Inc. compare | 40.2× |
| MTD Mettler-Toledo International, Inc. compare | 2,372× |
| Diagnostics & Research industry median | 3.1× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on RVTY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement